“…Numerous non-conventional and advanced imaging modalities are currently under investigation that may help improve visualization and quantification of (covert) tissue damage in the gray and white matter of the brain and the spinal cord and could be used as an imaging surrogate of remyelination and repair; among them are magnetization transfer imaging, diffusion tensor imaging, myelin water imaging, susceptibility weighted imaging, magnetic resonance spectroscopy, sodium imaging, PET imaging, ultra-high field imaging at 7 Tesla, functional imaging with resting state fMRI, T1/T2-weighted ratio calculable from conventional T1-and T2-weighted images, machine-learning based imaging, magnetic resonance elastography, and several others, none of which will probably be used in clinical practice in the near future (27,52,83,88,(118)(119)(120)(121)(122)(123)(124)(125)(126)(127)(128)(129)(130)(131)(132)(133)(134)(135). Nonetheless, these endeavors are important to deepen our understanding of mechanisms of tissue damage in MS and to devise better imaging endpoints for clinical trials and routine care than those currently in use.…”